@prefix n9j: <http://data.loterre.fr/ark:/67375/N9J> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix isothes: <http://purl.org/iso25964/skos-thes#> .

n9j:-ZNQ8VBJ8-R
  owl:sameAs <https://concepts.sagepub.com/social-science/concept/rimonabant> ;
  skos:definition "Rimonabant is the first inverse agonist discovered for the cannabinoid-1 receptor (CB1R) and is being developed for the treatment of obesity. Although rimonabant binds to the CB1R, it is not a cannabinoid-like compound and bears no structural resemblance to cannabinoids. [Source: Encyclopedia of Obesity; Rimonabant]"@en ;
  a skos:Concept ;
  skos:inScheme n9j: ;
  skos:broader n9j:-BZ3VRH22-V ;
  skos:prefLabel "rimonabant"@en .

n9j:-BZ3VRH22-V
  skos:prefLabel "new research frontiers on obesity"@en ;
  a skos:Concept ;
  skos:narrower n9j:-ZNQ8VBJ8-R .

n9j:-concepts
  a isothes:ConceptGroup ;
  skos:prefLabel "concepts"@en ;
  skos:member n9j:-ZNQ8VBJ8-R .

n9j: a skos:ConceptScheme .
